{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Neurodegenerative diseases", "Phytochemicals", "Plant derived alkaloids", "acetylcholinestrase", "butyrylcholinesterase", "monoamine oxidase."]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29559851", "DateCompleted": {"Year": "2019", "Month": "04", "Day": "05"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "12"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "03", "Day": "09"}], "Language": ["eng"], "ELocationID": ["10.7150/ijbs.23247"], "Journal": {"ISSN": "1449-2288", "JournalIssue": {"Volume": "14", "Issue": "3", "PubDate": {"Year": "2018"}}, "Title": "International journal of biological sciences", "ISOAbbreviation": "Int J Biol Sci"}, "ArticleTitle": "Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders.", "Pagination": {"StartPage": "341", "EndPage": "357", "MedlinePgn": "341-357"}, "Abstract": {"AbstractText": ["Neurodegenerative diseases are conventionally demarcated as disorders with selective loss of neurons. Conventional as well as newer molecules have been tested but they offer just symptomatic advantages along with abundant side effects. The discovery of more compelling molecules that can halt the pathology of these diseases will be considered as a miracle of present time. Several synthetic compounds are available but they may cause several other health issues. Therefore, natural molecules from the plants and other sources are being discovered to replace available medicines. In conventional medicational therapies, several plants have been reported to bestow remedial effects. Phytochemicals from medicinal plants can provide a better and safer alternative to synthetic molecules. Many phytochemicals have been identified that cure the human body from a number of diseases. The present article reviews the potential efficacy of plant-derived alkaloids, which possess potential therapeutic effects against several NDDs including Alzheimer's disease (AD), Huntington disease (HD), Parkinson's disease (PD), Epilepsy, Schizophrenia, and stroke. Alkaloids include isoquinoline, indole, pyrroloindole, oxindole, piperidine, pyridine, aporphine, vinca, \u03b2-carboline, methylxanthene, lycopodium, and erythrine byproducts. Alkaloids constitute positive roles in ameliorating pathophysiology of these illnesses by functioning as muscarinic and adenosine receptors agonists, anti-oxidant, anti-amyloid and MAO inhibitors, acetylcholinestrase and butyrylcholinesterase inhibitor, inhibitor of \u03b1-synuclein aggregation, dopaminergic and nicotine agonist, and NMDA antagonist."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Key Laboratory of Molecular Epigenetics of MOE, Institute of Genetics and Cytology, Northeast Normal University, Changchun 130024, China."}, {"Identifier": [], "Affiliation": "Department of Physiology, Faculty of Life Sciences, Government College University, Faisalabad, 38000 Pakistan."}], "LastName": "Hussain", "ForeName": "Ghulam", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Zoology, Faculty of Life Sciences, Government College University, Faisalabad, 38000 Pakistan."}, {"Identifier": [], "Affiliation": "Chemical Biology Research Group, RIKEN Center for Sustainable Resource Science. 2-1 Hirosawa, Wako, Saitama 351-0198 Japan."}], "LastName": "Rasul", "ForeName": "Azhar", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, Faculty of Life Sciences, Government College University, Faisalabad, 38000 Pakistan."}], "LastName": "Anwar", "ForeName": "Haseeb", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, Faculty of Life Sciences, Government College University, Faisalabad, 38000 Pakistan."}], "LastName": "Aziz", "ForeName": "Nimra", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, Faculty of Life Sciences, Government College University, Faisalabad, 38000 Pakistan."}], "LastName": "Razzaq", "ForeName": "Aroona", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Key Laboratory of Molecular Epigenetics of MOE, Institute of Genetics and Cytology, Northeast Normal University, Changchun 130024, China."}, {"Identifier": [], "Affiliation": "Dental Hospital, Jilin University, Changchun 130021, China."}], "LastName": "Wei", "ForeName": "Wei", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Zoology, Faculty of Life Sciences, Government College University, Faisalabad, 38000 Pakistan."}], "LastName": "Ali", "ForeName": "Muhammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Dental Hospital, Jilin University, Changchun 130021, China."}], "LastName": "Li", "ForeName": "Jiang", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Key Laboratory of Molecular Epigenetics of MOE, Institute of Genetics and Cytology, Northeast Normal University, Changchun 130024, China."}], "LastName": "Li", "ForeName": "Xiaomeng", "Initials": "X"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"]}, "MedlineJournalInfo": {"Country": "Australia", "MedlineTA": "Int J Biol Sci", "NlmUniqueID": "101235568", "ISSNLinking": "1449-2288"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Alkaloids"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neurodegenerative Diseases"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Phytochemicals"}], "CoiStatement": "Competing Interests: The authors have declared that no competing interest exists."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Kovacs GG. CURRENT CONCEPTS OF NEURODEGENERATIVE DISEASES. Cit EMJ Neurol. 2014;1(July):78\u201386."}, {"Citation": "Van Assche R, Temmerman L, Dias DA, Boughton B, Boonen K, Braeckman BP. et al. Metabolic profiling of a transgenic Caenorhabditis elegans Alzheimer model. Metabolomics. 2015;11(2):477\u201386.", "ArticleIdList": ["PMC4342517", "25750603"]}, {"Citation": "Hussain G, Shahzad A, Anwar H, Sohail MU, Baig SM, Shabbir A, Neurological disorder burden in Faisalabad, Punjab-Pakistan: data from the major tertiary care centers of the city. Pakistan J Neurol Sci; 2017. p. 12. (3)"}, {"Citation": "Kumar Gp, Khanum F. Neuroprotective potential of phytochemicals. Pharmacogn Rev [Internet] 2012;6(12):81.. Available from:  http://www.phcogrev.com/text.asp?2012/6/12/81/99898.", "ArticleIdList": ["PMC3459459", "23055633"]}, {"Citation": "Hussain G, Schmitt F, Henriques A, Lequeu T, Rene F, Bindler F. et al. Systemic down-regulation of delta-9 desaturase promotes muscle oxidative metabolism and accelerates muscle function recovery following nerve injury. PLoS One [Internet] 2013;8(6):e64525.. Available from:  http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3681796&tool=pmcentrez&rendertype=abstract.", "ArticleIdList": ["PMC3681796", "23785402"]}, {"Citation": "Hussain G, Schmitt F, Loeffler J-P, Gonzalez de Aguilar J-L. Fatting the brain: a brief of recent research. Front Cell Neurosci [Internet] 2013;7(September):144.. Available from:  http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3766822&tool=pmcentrez&rendertype=abstract.", "ArticleIdList": ["PMC3766822", "24058332"]}, {"Citation": "Schmitt F, Hussain G, Dupuis L, Loeffler J-P, Henriques A. A plural role for lipids in motor neuron diseases: energy, signaling and structure. Front Cell Neurosci [Internet] 2014;8(February):25.. Available from:  http://journal.frontiersin.org/article/10.3389/fncel.2014.00025/abstract.", "ArticleIdList": ["10.3389/fncel.2014.00025/abstract", "PMC3929843", "24600344"]}, {"Citation": "Cai Z, Wang C, Yang W. Role of berberine in Alzheimer's disease. Neuropsychiatric Disease and Treatment. 2016;12:2509\u201320.", "ArticleIdList": ["PMC5055107", "27757035"]}, {"Citation": "Kwon J, Seo YH, Lee JE, Seo EK, Li S, Guo Y. et al. Spiroindole Alkaloids and Spiroditerpenoids from Aspergillus duricaulis and Their Potential Neuroprotective Effects. J Nat Prod. 2015;78(11):2572\u20139.", "ArticleIdList": ["26517152"]}, {"Citation": "Nhan HS, Chiang K, Koo EH. The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes. Acta Neuropathologica. 2015;129:1\u201319.", "ArticleIdList": ["PMC4282969", "25287911"]}, {"Citation": "Baranello RJ, Bharani KL, Padmaraju V, Chopra N, Lahiri DK, Greig NH. et al. Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer's Disease. Curr Alzheimer Res. 2015;12:32\u201346.", "ArticleIdList": ["PMC4820400", "25523424"]}, {"Citation": "Kamagata K, Tomiyama H, Hatano T, Motoi Y, Abe O, Shimoji K. et al. A preliminary diffusional kurtosis imaging study of Parkinson disease: Comparison with conventional diffusion tensor imaging. Neuroradiology. 2014;56(3):251\u20138.", "ArticleIdList": ["24468858"]}, {"Citation": "Schrag A, Horsfall L, Walters K, Noyce A, Petersen I. Prediagnostic presentations of Parkinson's disease in primary care: A case-control study. Lancet Neurol. 2015;14(1):57\u201364.", "ArticleIdList": ["25435387"]}, {"Citation": "Palfi S, Gurruchaga JM, Ralph GS, Lepetit H, Lavisse S, Buttery PC. et al. Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial. Lancet. 2014;383(9923):1138\u201346.", "ArticleIdList": ["24412048"]}, {"Citation": "McNamara CG, Tejero-Cantero \u00c1, Trouche S, Campo-Urriza N, Dupret D. Dopaminergic neurons promote hippocampal reactivation and spatial memory persistence. Nat Neurosci. 2014;17(12):1658\u201360.", "ArticleIdList": ["PMC4241115", "25326690"]}, {"Citation": "Recasens A, Dehay B. Alpha-synuclein spreading in Parkinson\u00e2\u20acTMs disease. Front Neuroanat; 2014. p. 8.", "ArticleIdList": ["PMC4270285", "25565982"]}, {"Citation": "Schapira AH V, Olanow CW, Greenamyre JT, Bezard E. Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: Future therapeutic perspectives. Lancet. 2014;384(9942):545\u201355.", "ArticleIdList": ["24954676"]}, {"Citation": "Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, Huntington disease. Vol. 1, Nature Reviews Disease Primers; 2015.", "ArticleIdList": ["27188817"]}, {"Citation": "Sepers MD, Raymond LA. Mechanisms of synaptic dysfunction and excitotoxicity in Huntington's disease. Drug Discovery Today. 2014;19:990\u20136.", "ArticleIdList": ["24603212"]}, {"Citation": "Jiang W, Wei W, Gaertig MA, Li S, Li XJ. Therapeutic effect of berberine on Huntington's disease transgenic mouse model. PLoS One. 2015;10(7):1\u201316.", "ArticleIdList": ["PMC4520448", "26225560"]}, {"Citation": "Martin DDO, Ladha S, Ehrnhoefer DE, Hayden MR. Autophagy in Huntington disease and huntingtin in autophagy. Trends Neurosci. 2015;38(1):26\u201335.", "ArticleIdList": ["25282404"]}, {"Citation": "Vieweg S. The role of the polyglutamine and {N}-terminal domains in regulating the aggregation and structural properties of {H}untingtin {E}xon 1. [Lausanne]: EPFL; 2017."}, {"Citation": "Rawlins MD, Wexler NS, Wexler AR, Tabrizi SJ, Douglas I, Evans SJW, The prevalence of huntington's disease. Vol. 46, Neuroepidemiology; 2016. pp. 144\u201353.", "ArticleIdList": ["26824438"]}, {"Citation": "Kopyta I, Zimny M. Significant risk factors in the etiology of arterial ischemic stroke in children. CNS J. 2015;1(1):6\u201313."}, {"Citation": "Guo Y, Li P, Guo Q, Shang K, Yan D, Du S. et al. Pathophysiology and Biomarkers in Acute Ischemic Stroke - A Review. Trop J Pharm Res [Internet] 2014;12(6):1097.. Available from:  http://www.ajol.info/index.php/tjpr/article/view/99924."}, {"Citation": "Powers WJ, Derdeyn CP, Biller J, Coffey CS, Hoh BL, Jauch EC, 2015 AHA/ASA Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment. Stroke; 2015. STR.0000000000000074.", "ArticleIdList": ["26123479"]}, {"Citation": "Salinet ASM, Panerai RB, Robinson TG. The longitudinal evolution of cerebral blood flow regulation after acute ischaemic stroke. Cerebrovasc Dis Extra. 2014;4(2):186\u201397.", "ArticleIdList": ["PMC4176407", "25298773"]}, {"Citation": "Wang Y, Reis C, Applegate R, Stier G, Martin R, Zhang JH. Ischemic conditioning-induced endogenous brain protection: Applications pre-, per- or post-stroke. Vol. 272, Experimental neurology; 2015. pp. 26\u201340.", "ArticleIdList": ["PMC4609591", "25900056"]}, {"Citation": "Adilijiang A, Guan T, He J, Hartle K, Wang W, Li X. The protective effects of areca catechu extract on cognition and social interaction deficits in a cuprizone-induced demyelination model. Evidence-based Complement Altern Med; 2015. p. 2015.", "ArticleIdList": ["PMC4357051", "25815032"]}, {"Citation": "Ra\u010dki V, Petri\u0107 D, Ku\u010di\u0107 N, Gr\u017eeta N, Jurdana K, Ron\u010devi\u0107-Gr\u017eeta I. Cortical gray matter loss in schizophrenia: Could microglia be the culprit? Med Hypotheses. 2016;88:18\u201321.", "ArticleIdList": ["26880628"]}, {"Citation": "Kahn RS, Sommer IE, Murray RM, Meyer-Lindenberg A, Weinberger DR, Cannon TD, Schizophrenia. Nat Rev Dis Prim; 2015. p. 1.", "ArticleIdList": ["27189524"]}, {"Citation": "Snyder MA, Gao W-J. NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia. Front Cell Neurosci; 2013. p. 7.", "ArticleIdList": ["PMC3608949", "23543703"]}, {"Citation": "Choudhury B, Saytode P, Shah V. NEURODEGENRATIVE DISORDERS: PAST, PRESENT AND FUTURE. Int J Appl Pharm Biotechnol. 2014;5(2):14\u201328."}, {"Citation": "Girdhar S, Girdhar A, Verma SK, Lather V, Pandita D. Plant derived alkaloids in major neurodegenerative diseases\u202f: from animal models to clinical trials. J Ayurvedic Herb Med. 2015;1(3):91\u2013100."}, {"Citation": "Cushnie TPT, Cushnie B, Lamb AJ. Alkaloids: An overview of their antibacterial, antibiotic-enhancing and antivirulence activities. Vol. 44, International Journal of Antimicrobial Agents. Elsevier B.V. 2014. pp. 377\u201386.", "ArticleIdList": ["25130096"]}, {"Citation": "Ng YP, Or TCT, Ip NY. Plant alkaloids as drug leads for Alzheimer's disease. Neurochem Int. 2015 Oct;89:260\u201370.", "ArticleIdList": ["26220901"]}, {"Citation": "Amirkia V, Heinrich M. Alkaloids as drug leads - A predictive structural and biodiversity-based analysis. Phytochem Lett. 2014;10:xlviii\u2013liiii."}, {"Citation": "Abhijit Dey AM. Plant-Derived Alkaloids: A Promising Window for Neuroprotective Drug Discovery. In: Discovery and Development of Neuroprotective Agents from Natural Products; 2017. pp. 237\u2013320."}, {"Citation": "Cortes N, Posada-Duque RA, Alvarez R, Alzate F, Berkov S, Cardona-G\u00f3mez GP. et al. Neuroprotective activity and acetylcholinesterase inhibition of five Amaryllidaceae species: A comparative study. Life Sci. 2015;122:42\u201350.", "ArticleIdList": ["25529145"]}, {"Citation": "Imenshahidi M, Qaredashi R, Hashemzaei M, Hosseinzadeh H. Inhibitory effect of Berberis vulgaris aqueous extract on acquisition and reinstatement effects of morphine in conditioned place preferences (CPP) in mice. Jundishapur J Nat Pharm Prod; 2014. p. 9. (3)", "ArticleIdList": ["PMC4165176", "25237645"]}, {"Citation": "Jin Y, Khadka DB, Cho W-J. Pharmacological effects of berberine and its derivatives: a patent update. Expert Opin Ther Pat. 2016;26(2):229\u201343.", "ArticleIdList": ["26610159"]}, {"Citation": "Jiang WX, Li SH, Li XJ. Therapeutic potential of berberine against neurodegenerative diseases. Vol. 58, Science China Life Sciences; 2015. pp. 564\u20139.", "ArticleIdList": ["PMC5823536", "25749423"]}, {"Citation": "Jiang W, Wei W, Gaertig MA, Li S, Li XJ. Therapeutic effect of berberine on Huntington's disease transgenic mouse model. PLoS One; 2015. p. 10. (7)", "ArticleIdList": ["PMC4520448", "26225560"]}, {"Citation": "Mojarad TB, Roghani M. The anticonvulsant and antioxidant effects of berberine in kainate-induced temporal lobe epilepsy in rats. Basic Clin Neurosci. 2014;5(2):124\u201330.", "ArticleIdList": ["PMC4202588", "25337370"]}, {"Citation": "Zhu HL, Wan JB, Wang YT, Li BC, Xiang C, He J, Medicinal compounds with antiepileptic/anticonvulsant activities. Vol. 55, Epilepsia; 2014. pp. 3\u201316.", "ArticleIdList": ["24299155"]}, {"Citation": "Acqua SD. Plant-derived acetylcholinesterase inhibitory alkaloids for the treatment of Alzheimer ' s disease. Bot Targets Ther. 2013;3:19\u201328."}, {"Citation": "Kumar A, Singh A, Ekavali. A review on Alzheimer's disease pathophysiology and its management: An update. Vol. 67, Pharmacological Reports; 2015. pp. 195\u2013203.", "ArticleIdList": ["25712639"]}, {"Citation": "Mikkilineni S, Cantuti-Castelvetri I, Cahill CM, Balliedier A, Greig NH, Rogers JT. The anticholinesterase phenserine and its enantiomer posiphen as 5\u2032untranslated-region-directed translation blockers of the Parkinson's alpha synuclein expression. Parkinsons Dis. 2012;2012:5\u20138.", "ArticleIdList": ["PMC3368596", "22693681"]}, {"Citation": "Mishra A, Punia JK, Bladen C, Zamponi GW, Goel RK. Anticonvulsant mechanisms of piperine, a piperidine alkaloid. Channels. 2015;9(5):317\u201323.", "ArticleIdList": ["PMC4826125", "26542628"]}, {"Citation": "Hritcu L, Noumedem JA, Cioanca O, Hancianu M, Kuete V, Mihasan M. Methanolic Extract of Piper nigrum Fruits Improves Memory Impairment by Decreasing Brain Oxidative Stress in Amyloid Beta(1-42) Rat Model of Alzheimer's Disease. Cell Mol Neurobiol. 2014;34(3):437\u2013449.", "ArticleIdList": ["24442916"]}, {"Citation": "Al-Baghdadi OB, Prater NI, Van Der Schyf CJ, Geldenhuys WJ. Inhibition of monoamine oxidase by derivatives of piperine, an alkaloid from the pepper plant Piper nigrum, for possible use in Parkinson's disease. Bioorganic Med Chem Lett. 2012;22(23):7183\u20138.", "ArticleIdList": ["23102654"]}, {"Citation": "Carradori S, Ascenzio MD, Chimenti P, Secci D, Bolasco A. Selective MAO-B inhibitors\u202f: a lesson from natural products. Mol Divers. 2014;18:219\u201343.", "ArticleIdList": ["24218136"]}, {"Citation": "Dimatelis JJ, Russell VA, Stein DJ, Daniels WM. The effects of lobeline and naltrexone on methamphetamine-induced place preference and striatal dopamine and serotonin levels in adolescent rats with a history of maternal separation. Vol. 27, Metabolic Brain Disease; 2012. pp. 351\u201361.", "ArticleIdList": ["22392627"]}, {"Citation": "Xiao F, Yan B, Chen L, Zhou D. Review of the use of botanicals for epilepsy in complementary medical systems - Traditional Chinese Medicine. Vol. 52, Epilepsy and Behavior; 2015. pp. 281\u20139.", "ArticleIdList": ["26052078"]}, {"Citation": "Grizzell JA, Patel S, Barreto GE, Echeverria V. Cotinine improves visual recognition memory and decreases cortical Tau phosphorylation in the Tg6799 mice. Prog Neuro-Psychopharmacology Biol Psychiatry. 2017;78:75\u201381.", "ArticleIdList": ["28536070"]}, {"Citation": "Liu Y-J, Peng W, Hu M-B, Xu M, Wu C-J. The pharmacology, toxicology and potential applications of arecoline: a review. Pharm Biol. 2016;54(11):2753\u201360.", "ArticleIdList": ["27046150"]}, {"Citation": "Rivera-Oliver M, D\u00edaz-R\u00edos M. Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: A review. Vol. 101, Life Sciences; 2014. pp. 1\u20139.", "ArticleIdList": ["PMC4115368", "24530739"]}, {"Citation": "Wang H, Zhang K, Zhao L, Tang J, Gao L, Wei Z. Anti-inflammatory effects of vinpocetine on the functional expression of nuclear factor-kappa B and tumor necrosis factor-alpha in a rat model of cerebral ischemia-reperfusion injury. Neurosci Lett. 2014;566:247\u201351.", "ArticleIdList": ["24598438"]}, {"Citation": "Zhang F, Yan C, Wei C, Yao Y, Ma X, Gong Z, Vinpocetine Inhibits NF-\u03baB-Dependent Inflammation in Acute Ischemic Stroke Patients. Transl Stroke Res; 2017.", "ArticleIdList": ["28691141"]}, {"Citation": "Xing S, Zhu C, Zhang R, An L. Huperzine A in the Treatment of Alzheimer's Disease and Vascular Dementia: A Meta-Analysis. Evidence-Based Complement Altern Med. 2014;2014:1\u201310.", "ArticleIdList": ["PMC3930088", "24639880"]}, {"Citation": "Yadav M, Parle M, Sharma N, Ghimire K, Khare N. Role of Bioactive Phytoconstituents from Several Traditional Herbs as Natural Neuroprotective Agents Role of Bioactive Phytoconstituents from Several Traditional Herbs as Natural Neuroprotective Agents. 2016;(August)"}, {"Citation": "Dakic V, Maciel R de M, Drummond H, Nascimento JM, Trindade P, Rehen SK. Harmine stimulates proliferation of human neural progenitors. PeerJ. 2016;4:e2727.", "ArticleIdList": ["PMC5144684", "27957390"]}, {"Citation": "Faggion SA, Cunha AOS, Fachim HA, Gavin AS, dos Santos WF, Pereira AMS. et al. Anticonvulsant profile of the alkaloids (+)-erythravine and (+)-11-\u03b1-hydroxy-erythravine isolated from the flowers of Erythrina mulungu Mart ex Benth (Leguminosae-Papilionaceae) Epilepsy Behav. 2011;20(3):441\u20136.", "ArticleIdList": ["21277832"]}, {"Citation": "Setti-Perdig\u00e3o P, Serrano MAR, Flausino OA, Bolzani VS, Guimar\u00e3es MZP, Castro NG. Erythrina mulungu alkaloids are potent inhibitors of neuronal nicotinic receptor currents in mammalian cells. PLoS One. 2013;8(12):8\u201313.", "ArticleIdList": ["PMC3862643", "24349349"]}, {"Citation": "Patil S, Tawari S, Mundhada D, Nadeem S. Protective effect of berberine, an isoquinoline alkaloid ameliorates ethanol-induced oxidative stress and memory dysfunction in rats. Pharmacol Biochem Behav. 2015;136:13\u201320.", "ArticleIdList": ["26159088"]}, {"Citation": "Han AM, Heo H, Kwon YK. Berberine Promotes Axonal Regeneration in Injured Nerves of the Peripheral Nervous System. J Med Food [Internet] 2012;15(4):413\u20137. Available from:  http://online.liebertpub.com/doi/abs/10.1089/jmf.2011.2029.", "ArticleIdList": ["10.1089/jmf.2011.2029", "PMC3308712", "22316297"]}, {"Citation": "Yan R, Vassar R. Targeting the \u03b2 secretase BACE1 for Alzheimer's disease therapy. Vol. 13, The Lancet Neurology; 2014. pp. 319\u201329.", "ArticleIdList": ["PMC4086426", "24556009"]}, {"Citation": "Panahi N, Mahmoudian M, Mortazavi P, Hashjin GS. Effects of berberine on beta-secretase activity in a rabbit model of Alzheimer's disease. Arch Med Sci [Internet] 2013;9(1):146\u201350. Available from:  http://www.ncbi.nlm.nih.gov/pubmed/23516061.", "ArticleIdList": ["PMC3598150", "23516061"]}, {"Citation": "Mathew B, Suresh J, Mathew GE, Parasuraman R, Abdulla N. Plant secondary metabolites- potent inhibitors of monoamine oxidase isoforms. Cent Nerv Syst Agents Med Chem. 2014;14(1):28\u201333.", "ArticleIdList": ["25142815"]}, {"Citation": "Pohanka M. Inhibitors of acetylcholinesterase and butyrylcholinesterase meet immunity. Vol. 15, International Journal of Molecular Sciences; 2014. pp. 9809\u201325.", "ArticleIdList": ["PMC4100123", "24893223"]}, {"Citation": "Huang M, Jiang X, Liang Y, Liu Q, Chen S, Guo Y. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of \u03b2-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease. Exp Gerontol. 2017;91:25\u201333.", "ArticleIdList": ["28223223"]}, {"Citation": "Kim M, Cho KIHO, Shin MS, Lee JM, Cho HS, Kim CJU. et al. Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease. Int J Mol Med. 2014;33(4):870\u20138.", "ArticleIdList": ["24535622"]}, {"Citation": "Zhang Q, Bian H, Guo L, Zhu H. Pharmacologic preconditioning with berberine attenuating ischemia-induced apoptosis and promoting autophagy in neuron. Am J Transl Res. 2016;8(2):1197\u2013207.", "ArticleIdList": ["PMC4846963", "27158406"]}, {"Citation": "Ciechanover A, Kwon YT. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med. 2015;47(3):e147.", "ArticleIdList": ["PMC4351408", "25766616"]}, {"Citation": "Parsons MP, Raymond LA. Extrasynaptic NMDA receptor involvement in central nervous system disorders. Neuron. 2014;82(2):279\u201393.", "ArticleIdList": ["24742457"]}, {"Citation": "Chen C, Yu Z, Li Y, Fichna J, Storr M. Effects of Berberine in the Gastrointestinal Tract \u2014 A Review of Actions and Therapeutic Implications. Am J Chin Med. 2014;42(5):1053\u201370.", "ArticleIdList": ["25183302"]}, {"Citation": "Godugu C, Patel AR, Doddapaneni R, Somagoni J, Singh M. Approaches to improve the oral bioavailability and effects of novel anticancer drugs berberine and betulinic acid. PLoS One; 2014. p. 9. (3)", "ArticleIdList": ["PMC3948684", "24614362"]}, {"Citation": "Pang B, Zhao L, Zhou Q, Zhao T, Wang H, Gu C, Review Article Application of Berberine on Treating Type 2 Diabetes Mellitus. Int J Endocrinol; 2015. p. 2015.", "ArticleIdList": ["PMC4377488", "25861268"]}, {"Citation": "Kaur R, Arora S. Alkaloids- Important Therapeutic Secondary Metabolites Of Plant Origin. J Crit Rev. 2015;2(3):1\u20138."}, {"Citation": "Ye D, Bu H, Guo G, Shu B, Wang W, Guan X. et al. Activation of CXCL10/CXCR3 signaling attenuates morphine analgesia: Involvement of Gi protein. J Mol Neurosci. 2014;53(4):571\u20139.", "ArticleIdList": ["24415274"]}, {"Citation": "Cui J, Wang Y, Dong Q, Wu S, Xiao X, Hu J. et al. Morphine Protects against Intracellular Amyloid Toxicity by Inducing Estradiol Release and Upregulation of Hsp70. J Neurosci [Internet] 2011;31(45):16227\u201340. Available from:  http://www.jneurosci.org/cgi/doi/10.1523/JNEUROSCI.3915-11.2011.", "ArticleIdList": ["10.1523/JNEUROSCI.3915-11.2011", "PMC6633253", "22072674"]}, {"Citation": "Almeida MB, Costa-Malaquias A, Nascimento JLM, Oliveira KR, Herculano AM, Crespo-L\u00f3pez ME. Therapeutic concentration of morphine reduces oxidative stress in glioma cell line. Brazilian J Med Biol Res. 2014;47(5):398\u2013402.", "ArticleIdList": ["PMC4075308", "24728211"]}, {"Citation": "Wang Y, Wang YX, Liu T, Law PY, Loh HH, Qiu Y. et al. \u03bc-Opioid Receptor Attenuates A\u03b2 Oligomers-Induced Neurotoxicity Through mTOR Signaling. CNS Neurosci Ther. 2015;21(1):8\u201314.", "ArticleIdList": ["PMC6495561", "25146548"]}, {"Citation": "Berger JS, Gonzalez A, Hopkins A, Alshaeri T, Jeon D, Wang S, Dose-response of intrathecal morphine when administered with intravenous ketorolac for post-cesarean analgesia: a two-center, prospective, randomized, blinded trial. In: International Journal of Obstetric Anesthesia; 2016. pp. 3\u201311.", "ArticleIdList": ["27717635"]}, {"Citation": "Ding X, Jin S, Niu X, Wang T, Zhao X, Ren H. et al. Morphine with adjuvant ketamine versus higher dose of morphine alone for acute pain: A meta-analysis. Int J Clin Exp Med. 2014;7(9):2504\u201310.", "ArticleIdList": ["PMC4211753", "25356103"]}, {"Citation": "Ghafari S, Golalipour MJ. Prenatal morphine exposure reduces pyramidal neurons in CA1, CA2 and CA3 subfields of mice hippocampus. Iran J Basic Med Sci. 2014;17(3):155\u201361.", "ArticleIdList": ["PMC4016685", "24847417"]}, {"Citation": "Moraga F, Hormaz\u00e1bal E, Venthur H, Quiroz A, Mutis A. REVIEW ARTICLE ALKALOID DISCOVERY AS NATURAL ACETYLCHOLINESTERASE INHIBITORS, FROM NATURE TO MOLECULAR DOCKING. Rev Farm Chile. 2016;9(56):16\u201325."}, {"Citation": "de Andrade JP, Giordani RB, Torras-Claveria L, Pigni NB, Berkov S, Font-Bardia M. et al. The Brazilian Amaryllidaceae as a source of acetylcholinesterase inhibitory alkaloids. Phytochem Rev. 2016;15(1):147\u201360."}, {"Citation": "Rocha L, Alonso-Vanegas M, Mart\u00c3nez-Ju\u00c3\u00a1rez IE, Orozco-Su\u00c3\u00a1rez S, Escalante-Santiago D, Feria-Romero IA, GABAergic Alterations in Neocortex of Patients with Pharmacoresistant Temporal Lobe Epilepsy Can Explain the Comorbidity of Anxiety and Depression: The Potential Impact of Clinical Factors. Front Cell Neurosci; 2015. p. 8.", "ArticleIdList": ["PMC4283637", "25601827"]}, {"Citation": "Golechha M, Sarangal V, Bhatia J, Chaudhry U, Saluja D, Arya DS. Naringin ameliorates pentylenetetrazol-induced seizures and associated oxidative stress, inflammation, and cognitive impairment in rats: Possible mechanisms of neuroprotection. Epilepsy Behav. 2014;41:98\u2013102.", "ArticleIdList": ["25461197"]}, {"Citation": "Pagliosa LB, Monteiro SC, Silva KB, de Andrade JP, Dutilh J, Bastida J. et al. Effect of isoquinoline alkaloids from two Hippeastrum species on in vitro acetylcholinesterase activity. Phytomedicine. 2010;17(8-9):698\u2013701.", "ArticleIdList": ["19969445"]}, {"Citation": "Tundis R, Menichini F, Conforti F, Loizzo MR, Bonesi M, Statti G. et al. A potential role of alkaloid extracts from Salsola species (Chenopodiaceae) in the treatment of Alzheimer's disease. J Enzyme Inhib Med Chem. 2009;24(3):818\u201324.", "ArticleIdList": ["18720188"]}, {"Citation": "Orhan IE, Kucukboyaci N, Calis I, Cer\u00f3n-Carrasco JP, den-Haan H, Pe\u00f1a-Garc\u00eda J. et al. Acetylcholinesterase inhibitory assessment of isolated constituents from Salsola grandis Freitag, Vural & Ad\u0131g\u00fczel and molecular modeling studies on N-acetyltryptophan. Phytochem Lett. 2017;20:373\u20138."}, {"Citation": "H. Ferreira-Vieira T, M. Guimaraes I, R. Silva F, M. Ribeiro F. Alzheimer's disease: Targeting the Cholinergic System. Curr Neuropharmacol. 2016;14(1):101\u201315.", "ArticleIdList": ["PMC4787279", "26813123"]}, {"Citation": "Chen T-H, Chou M-C, Lai C-L, Wu S-J, Hsu C-L, Yang Y-H. Factors affecting therapeutic response to Rivastigmine in Alzheimer's disease patients in Taiwan. Kaohsiung J Med Sci. 2017;33(6):277\u201383.", "ArticleIdList": ["28601231"]}, {"Citation": "Kim JK, Park SU. Pharmacological aspects of galantamine for the treatment of Alzheimer's disease. Vol. 16, EXCLI Journal; 2017. pp. 35\u20139.", "ArticleIdList": ["PMC5318685", "28337117"]}, {"Citation": "Lombardo S, Maskos U. Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment. Neuropharmacology. 2015;96(PB):255\u201362.", "ArticleIdList": ["25514383"]}, {"Citation": "Raskind MA, Peskind ER, Wessel T, Yuan W. Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group. Neurology. 2000 Jun;54(12):2261\u20138.", "ArticleIdList": ["10881250"]}, {"Citation": "Fuentealba J, Saez-Orellana F. Neuroactive alkaloids that modulate the neuronal nicotinic receptor and provide neuroprotection in an Alzheimer???s disease model: The case of teline monspessulana. Neural Regen Res. 2014;9(21):1880\u20131.", "ArticleIdList": ["PMC4281424", "25558235"]}, {"Citation": "Dineley KT, Pandya AA, Yakel JL. Nicotinic ACh receptors as therapeutic targets in CNS disorders. Vol. 36, Trends in Pharmacological Sciences; 2015. pp. 96\u2013108.", "ArticleIdList": ["PMC4324614", "25639674"]}, {"Citation": "Nikiforuk A, Kos T, Potasiewicz A, Popik P. Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats. Eur Neuropsychopharmacol. 2015;25(8):1300\u201313.", "ArticleIdList": ["26003081"]}, {"Citation": "Kita Y, Ago Y, Higashino K, Asada K, Takano E, Takuma K. et al. Galantamine promotes adult hippocampal neurogenesis via M1 muscarinic and \u03b17 nicotinic receptors in mice. Int J Neuropsychopharmacol [Internet] 2014;17(12):1957\u201368. Available from:  https://academic.oup.com/ijnp/article-lookup/doi/10.1017/S1461145714000613.", "ArticleIdList": ["10.1017/S1461145714000613", "24818616"]}, {"Citation": "Abd El-Wahab AE, Ghareeb DA, Sarhan EEM, Abu-Serie MM, El Demellawy MA. In vitro biological assessment of berberis vulgaris and its active constituent, berberine: Antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects. BMC Complement Altern Med. 2013;13(1):218.", "ArticleIdList": ["PMC4016550", "24007270"]}, {"Citation": "Castillo WO, Aristizabal-Pachon AF. Galantamine protects against beta amyloid peptide-induced DNA damage in a model for Alzheimer's disease. Vol. 12, Neural Regeneration Research; 2017. pp. 916\u20137.", "ArticleIdList": ["PMC5514865", "28761423"]}, {"Citation": "Bhattacharya S, Haertel C, Maelicke A, Montag D. Galantamine slows down plaque formation and behavioral decline in the 5XFAD mouse model of Alzheimer's disease. PLoS One; 2014. p. 9. (2)", "ArticleIdList": ["PMC3931790", "24586789"]}, {"Citation": "Hager K, Baseman AS, Nye JS, Brashear HR, Han J, Sano M. et al. Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease. Neuropsychiatr Dis Treat. 2014;10:391\u2013401.", "ArticleIdList": ["PMC3937252", "24591834"]}, {"Citation": "Woo FY, Basri M, Masoumi HRF, Ahmad MB, Ismail M. Formulation optimization of galantamine hydrobromide loaded gel drug reservoirs in transdermal patch for Alzheimer's disease. Int J Nanomedicine. 2015;10:3879\u201386.", "ArticleIdList": ["PMC4462858", "26089664"]}, {"Citation": "Caramelli P, Laks J, Palmini ALF, Nitrini R, Chaves MLF, Forlenza OV. et al. Effects of galantamine and galantamine combined with nimodipine on cognitive speed and quality of life in mixed dementia: a 24-week, randomized, placebo-controlled exploratory trial (the REMIX study) Arq Neuropsiquiatr. 2014;72(6):411\u20137.", "ArticleIdList": ["24964105"]}, {"Citation": "Lima JA, Costa TWR, Silva LL, Miranda ALP, Pinto AC. Antinociceptive and anti-inflammatory effects of a Geissospermum Vellosii stem bark fraction. An Acad Bras Cienc. 2016;88(1):237\u201348.", "ArticleIdList": ["26840005"]}, {"Citation": "Sajkowska-Kozielewicz JJ, Kozielewicz P, Barnes NM, Wawer I, Paradowska K. Antioxidant, Cytotoxic, and Antiproliferative Activities and Total Polyphenol Contents of the Extracts of Geissospermum reticulatum Bark. Oxid Med Cell Longev; 2016. p. 2016.", "ArticleIdList": ["PMC4942660", "27446507"]}, {"Citation": "Reina M, Ruiz-Mesia W, L\u00f3pez-Rodr\u00edguez M, Ruiz-Mesia L, Gonz\u00e1lez-Coloma A, Mart\u00ednez-D\u00edaz R. Indole alkaloids from Geissospermum reticulatum. J Nat Prod. 2012;75(5):928\u201334.", "ArticleIdList": ["22551062"]}, {"Citation": "Vital MJS, Carneiro ALB, Rocha LF, das Neves Amorim RC, Camargo MRM, Pohlit AM. Chemical composition, ethnopharmacology and biological activity of Geissospermum Allem\u00e3o species (Apocynaceae Juss.) Rev Fitos Eletr\u00f4nica. 2015;8(2):137\u201346."}, {"Citation": "Ara\u00fajo JQ, Lima JA, Pinto ADC, De Alencastro RB, Albuquerque MG. Docking of the alkaloid geissospermine into acetylcholinesterase: A natural scaffold targeting the treatment of Alzheimer's disease. J Mol Model. 2011;17(6):1401\u201312.", "ArticleIdList": ["20844909"]}, {"Citation": "Shaikh S, Verma A, Siddiqui S, Ahmad SS, Rizvi SMD, Shakil S. et al. Current acetylcholinesterase-inhibitors: A neuroinformatics perspective. CNS Neurol Disord - Drug Targets. 2014;13(3):391\u2013401.", "ArticleIdList": ["24059296"]}, {"Citation": "Orhan G, Orhan I, Subutay-Oztekin N, Ak F, Sener B. Contemporary Anticholinesterase Pharmaceuticals of Natural Origin and Their Synthetic Analogues for the Treatment of Alzheimers Disease. Recent Pat CNS Drug Discov [Internet] 2009;4(1):43\u201351. Available from:  http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1574-8898&volume=4&issue=1&spage=43.", "ArticleIdList": ["19149713"]}, {"Citation": "Mohamed LA, Keller JN, Kaddoumi A. Biochimica et Biophysica Acta Role of P-glycoprotein in mediating rivastigmine effect on amyloid- \u03b2 brain load and related pathology in Alzheimer \u00e2\u20acTM s disease mouse model. BBA - Mol Basis Dis. 2016;1862(4):778\u201387.", "ArticleIdList": ["PMC4788561", "26780497"]}, {"Citation": "Wiese AJ, Brosnan RJ, Barter LS. Effects of acetylcholinesterase inhibition on quality of recovery from isoflurane-induced anesthesia in horses. Am J Vet Res. 2014;75(3):223\u201330.", "ArticleIdList": ["24564307"]}, {"Citation": "Tie H-T, Su G-Z, He K, Liang S-R, Yuan H-W, Mou J-H. Efficacy and safety of ondansetron in preventing postanesthesia shivering: a meta-analysis of randomized controlled trials. BMC Anesthesiol. 2014;14:12.", "ArticleIdList": ["PMC3945808", "24588846"]}, {"Citation": "Wenger E, McDermott R, Synder W. Cultivating communities of pratice a guide to managing knowledge. J Knowl Manag Pract. 2002;24(2):304."}, {"Citation": "Guo H, Zhang X, Cui Y, Deng W, Xu D, Han H. et al. Isorhynchophylline protects against pulmonary arterial hypertension and suppresses PASMCs proliferation. Biochem Biophys Res Commun. 2014;450(1):729\u201334.", "ArticleIdList": ["24950404"]}, {"Citation": "Zhou JY, Zhou SW. Isorhynchophylline: A plant alkaloid with therapeutic potential for cardiovascular and central nervous system diseases. Vol. 83, Fitoterapia; 2012. pp. 617\u201326.", "ArticleIdList": ["22406453"]}, {"Citation": "Ho TY, Tang NY, Hsiang CY, Hsieh CL. Uncaria rhynchophylla and rhynchophylline improved kainic acid-induced epileptic seizures via IL-1\u03b2 and brain-derived neurotrophic factor. Phytomedicine. 2014;21(6):893\u2013900.", "ArticleIdList": ["24636743"]}, {"Citation": "Tsuji M, Takeuchi T, Miyagawa K, Ishii D, Imai T, Takeda K. et al. Yokukansan, a traditional Japanese herbal medicine, alleviates the emotional abnormality induced by maladaptation to stress in mice. Phytomedicine. 2014;21(3):363\u201371.", "ArticleIdList": ["24129119"]}, {"Citation": "WEN-JUAN HUANG, XIA ZHANG, W-WC. Role of oxidative stress in Alzheimer's disease. Biomed Rep; 2016. pp. 519\u2013522.", "ArticleIdList": ["PMC4840676", "27123241"]}, {"Citation": "Xian YF, Lin ZX, Mao QQ, Ip SP, Su ZR, Lai XP. Protective effect of isorhynchophylline against \u03b2-amyloid-induced neurotoxicity in PC12 cells. Cell Mol Neurobiol. 2012;32(3):353\u201360.", "ArticleIdList": ["22042506"]}, {"Citation": "Xian YF, Mao QQ, Wu JCY, Su ZR, Chen JN, Lai XP. et al. Isorhynchophylline treatment improves the amyloid-\u03b2-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation. J Alzheimer's Dis. 2014;39(2):331\u201346.", "ArticleIdList": ["24164737"]}, {"Citation": "Akl H, Vervloessem T, Kiviluoto S, Bittremieux M, Parys JB, De Smedt H, A dual role for the anti-apoptotic Bcl-2 protein in cancer: Mitochondria versus endoplasmic reticulum. Vol. 1843, Biochimica et Biophysica Acta - Molecular Cell Research; 2014. pp. 2240\u201352.", "ArticleIdList": ["24768714"]}, {"Citation": "Cooper JM, Wiklander PBO, Nordin JZ, Al-Shawi R, Wood MJ, Vithlani M. et al. Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice. Mov Disord. 2014;29(12):1476\u201385.", "ArticleIdList": ["PMC4204174", "25112864"]}, {"Citation": "Zhang H, Bai L, He J, Zhong L, Duan X, Ouyang L. et al. Recent advances in discovery and development of natural products as source for anti-Parkinson's disease lead compounds. Eur J Med Chem. 2017;141:257\u201372.", "ArticleIdList": ["29031072"]}, {"Citation": "Lu J-H, Tan J-Q, Durairajan SSK, Liu L-F, Zhang Z-H, Ma L. et al. Isorhynchophylline, a natural alkaloid, promotes the degradation of alpha-synuclein in neuronal cells via inducing autophagy. Autophagy. 2012;8(1):98\u2013108.", "ArticleIdList": ["22113202"]}, {"Citation": "Ghavami S, Shojaei S, Yeganeh B, Ande SR, Jangamreddy JR, Mehrpour M. et al. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol. 2014;112:24\u201349.", "ArticleIdList": ["24211851"]}, {"Citation": "Yeggoni DP, Rachamallu A, Kallubai M, Subramanyam R. Cytotoxicity and comparative binding mechanism of piperine with human serum albumin and \u03b1-1-acid glycoprotein. J Biomol Struct Dyn. 2015;33(6):1336\u201351.", "ArticleIdList": ["25054206"]}, {"Citation": "Damanhouri ZA. A Review on Therapeutic Potential of Piper nigrum L. (Black Pepper): The King of Spices. Med Aromat Plants; 2014. p. 3. (3)"}, {"Citation": "Vasavirama K, Upender M. Piperine: A valuable alkaloid from piper species. Vol. 6, International Journal of Pharmacy and Pharmaceutical Sciences; 2014. pp. 34\u20138."}, {"Citation": "Goswami PK, Samant M, Srivastava RS. Snake venom, anti-snake venom & potential of snake venom. Int J Pharm Pharm Sci. 2014;6(5):4\u20137."}, {"Citation": "Hirose S. Mutant GABAA receptor subunits in genetic (idiopathic) epilepsy. In: Genetics of Epilepsy; 2014. pp. 55\u201385.", "ArticleIdList": ["25194483"]}, {"Citation": "Murata K, Matsumura S, Yoshioka Y, Ueno Y, Matsuda H. Screening of \u03b2-secretase and acetylcholinesterase inhibitors from plant resources. J Nat Med. 2015;69(1):123\u2013129.", "ArticleIdList": ["25119528"]}, {"Citation": "Rinwa P, Kumar A. Quercetin along with piperine prevents cognitive dysfunction, oxidative stress and neuro-inflammation associated with mouse model of chronic unpredictable stress. Arch Pharm Res. 2017;40(10):1166\u201375.", "ArticleIdList": ["23856969"]}, {"Citation": "Shrivastava P, Vaibhav K, Tabassum R, Khan A, Ishrat T, Khan MM. et al. Anti-apoptotic and Anti-inflammatory effect of Piperine on 6-OHDA induced Parkinson's Rat model. J Nutr Biochem. 2013;24(4):680\u20137.", "ArticleIdList": ["22819561"]}, {"Citation": "Shailendra Wadhwa, Sarita Singhal SR. Bioavailability Enhancement by Piperine: A Review. Asian J Biomed Pharm Sci; 2014. pp. 1\u20138."}, {"Citation": "Li CY, Zhao LM, Shi XW, Zhang JD. Lobeline shows protective effects against MPTP-induced dopaminergic neuron death and attenuates behavior deficits in animalsz. Exp Ther Med. 2014;7(2):375\u20138.", "ArticleIdList": ["PMC3881066", "24396408"]}, {"Citation": "Martin CA, Nuzzo PA, Ranseen JD, Kleven MS, Guenthner G, Williams Y, Lobeline Effects on Cognitive Performance in Adult ADHD. J Atten Disord; 2013.", "ArticleIdList": ["PMC4062608", "23966351"]}, {"Citation": "Angeles ML, Kapadia N, Harding W. Aporphine Alkaloids as Ligands for Serotonin Receptors. Med Chem (Los Angeles) 2016;6(4):241\u20139."}, {"Citation": "Steinlein OK. Calcium signaling and epilepsy. Vol. 357, Cell and Tissue Research; 2014. pp. 385\u201393.", "ArticleIdList": ["24723228"]}, {"Citation": "Ribeiro RA, Leite JR. Nantenine alkaloid presents anticonvulsant effect on two classical animal models. Phytomedicine. 2003;10(6-7):563\u20138.", "ArticleIdList": ["13678244"]}, {"Citation": "Kharkwal G, Brami-Cherrier K, Lizardi-Ortiz JE, Nelson AB, Ramos M, Del Barrio D. et al. Parkinsonism Driven by Antipsychotics Originates from Dopaminergic Control of Striatal Cholinergic Interneurons. Neuron. 2016;91(1):67\u201378.", "ArticleIdList": ["PMC4939839", "27387649"]}, {"Citation": "Barreto G, Iarkov A, Moran V.  Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease. Front Aging Neurosci [Internet]; 2014. pp. 1\u201313. Available from:  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288130/", "ArticleIdList": ["PMC4288130", "25620929"]}, {"Citation": "Fargo K. Alzheimer's Association Report: 2014 Alzheimers disease facts and figures. Alzheimer's Dement; 2014. p. 10. (2)", "ArticleIdList": ["24818261"]}, {"Citation": "Akaike A, Takada-Takatori Y, Kume T, Izumi Y. Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: Role of \u03b14 and \u03b17 receptors in neuroprotection. In: Journal of Molecular Neuroscience; 2010. pp. 211\u20136.", "ArticleIdList": ["19714494"]}, {"Citation": "Kim BG, Jee \u00c6SW, Lee \u00c6SH, Sin \u00c6JS, Bae \u00c6CJ, Lee BC, Nicotine Leads to Improvements in Behavioral Impairment and an Increase in the Nicotine Acetylcholine Receptor in Transgenic Mice. 2008;1783-8.", "ArticleIdList": ["18307030"]}, {"Citation": "Levy DT, Cummings KM, Villanti AC, Niaura R, Abrams DB, Fong GT. et al. A framework for evaluating the public health impact of e-cigarettes and other vaporized nicotine products. Addiction. 2017;112(1):8\u201317.", "ArticleIdList": ["PMC5079857", "27109256"]}, {"Citation": "Mayer B. How much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious self-experiments in the nineteenth century. Archives of Toxicology. 2014;88(1):5\u20137.", "ArticleIdList": ["PMC3880486", "24091634"]}, {"Citation": "Pelissier-Rota MA, Pelosi L, Meresse P, Jacquier-Sarlin MR. Nicotine-induced cellular stresses and autophagy in human cancer colon cells: A supportive effect on cell homeostasis via up-regulation of Cox-2 and PGE<inf>2</inf> production. Int J Biochem Cell Biol. 2015;65:239\u201356.", "ArticleIdList": ["26100595"]}, {"Citation": "Bhat SK, Ashwin D, Sarpangala M. Contamination and Adulteration in Arecanut ( Areca Catechu L.) And Its Chewing Foms\u202f: The Less Focused Subject by Health Researchers. 2017;11(1):7-12."}, {"Citation": "Carruthers SP, Gurvich CT, Rossell SL. The muscarinic system, cognition and schizophrenia. Neurosci Biobehav Rev. 2015;55:393\u2013402.", "ArticleIdList": ["26003527"]}, {"Citation": "Coppola M, Mondola R. Potential action of betel alkaloids on positive and negative symptoms of schizophrenia: A review. Vol. 66, Nordic Journal of Psychiatry; 2012. pp. 73\u20138.", "ArticleIdList": ["21859398"]}, {"Citation": "Woo TUW. Neurobiology of schizophrenia onset. Curr Top Behav Neurosci. 2014;16:267\u201395.", "ArticleIdList": ["PMC4447495", "23975845"]}, {"Citation": "Bales A, Peterson MJ, Ojha S, Upadhaya K, Adhikari B, Barrett B. Associations between betel nut (Areca catechu) and symptoms of schizophrenia among patients in Nepal: A longitudinal study. Psychiatry Res. 2009;169(3):203\u201311.", "ArticleIdList": ["19748131"]}, {"Citation": "Thal DM, Sun B, Feng D, Nawaratne V, Leach K, Felder CC. et al. Crystal structures of the M1 and M4 muscarinic acetylcholine receptors. Nature. 2016;531(7594):335\u201340.", "ArticleIdList": ["PMC4915387", "26958838"]}, {"Citation": "Crook JM, Tomaskovic-Crook E, Copolov DL, Dean B. Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation. Biol Psychiatry. 2000;48(5):381\u20138.", "ArticleIdList": ["10978721"]}, {"Citation": "Cotter D. Reduced Neuronal Size and Glial Cell Density in Area 9 of the Dorsolateral Prefrontal Cortex in Subjects with Major Depressive Disorder. Cereb Cortex. 2002;12(4):386\u201394.", "ArticleIdList": ["11884354"]}, {"Citation": "Deng C, Huang X-F. Decreased density of muscarinic receptors in the superior temporal gyrusin schizophrenia. J Neurosci Res. 2005;81(6):883\u201390.", "ArticleIdList": ["16041805"]}, {"Citation": "Peng W, Liu Y-J, Wu N, Sun T, He X-Y, Gao Y-X. et al. Areca catechu L. (Arecaceae): A review of its traditional uses, botany, phytochemistry, pharmacology and toxicology. J Ethnopharmacol. 2015;164(Supplement C):340\u201356.", "ArticleIdList": ["25681543"]}, {"Citation": "Zhou J, Sun Q, Yang Z, Zhang J. The Hepatotoxicity and Testicular Toxicity Induced by Arecoline in Mice and Protective Effects of Vitamins C and E. Korean J Physiol Pharmacol. 2014;18(2):143.", "ArticleIdList": ["PMC3994301", "24757376"]}, {"Citation": "Cheng S-J, Ko H-H, Cheng S-L, Lee J-J, Chen H-M, Chang H-H. et al. Arecoline-stimulated placenta growth factor production in gingival epithelial cells: modulation by curcumin. Oral Dis. 2013;19(5):513\u20138.", "ArticleIdList": ["23163860"]}, {"Citation": "Ullah M, Cox S, Kelly E, Boadle R, Zoellner H. Arecoline is cytotoxic for human endothelial cells. J Oral Pathol Med. 2014;43(10):761\u20139.", "ArticleIdList": ["24761785"]}, {"Citation": "McIntire LK, McKinley RA, Goodyear C, Nelson J. A comparison of the effects of transcranial direct current stimulation and caffeine on vigilance and cognitive performance during extended wakefulness. Brain Stimul. 2014;7(4):499\u2013507.", "ArticleIdList": ["25047826"]}, {"Citation": "Arendash GW, Mori T, Cao C, Mamcarz M, Runfeldt M, Dickson A. et al. Caffeine reverses cognitive impairment and decreases brain amyloid-\u03b2 levels in aged alzheimer's disease mice. J Alzheimer's Dis. 2009;17(3):661\u201380.", "ArticleIdList": ["19581722"]}, {"Citation": "Collin L, Bohrmann B, G\u00f6pfert U, Oroszlan-Szovik K, Ozmen L, Gr\u00fcninger F. Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer's disease. Brain. 2014;137(10):2834\u201346.", "ArticleIdList": ["25085375"]}, {"Citation": "Laurent C, Eddarkaoui S, Derisbourg M, Leboucher A, Demeyer D, Carrier S. et al. Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology. Neurobiol Aging. 2014;35(9):2079\u201390.", "ArticleIdList": ["24780254"]}, {"Citation": "Nehlig A. Effects of coffee/caffeine on brain health and disease: What should I tell my patients? Pract Neurol. 2016;16(2):89\u201395.", "ArticleIdList": ["26677204"]}, {"Citation": "Ritchie K, Carri\u00e8re I, de Mendon\u00e7a A, Portet F, Dartigues JF, Rouaud O. et al. The neuroprotective effects of caffeine: a prospective population study (the Three City Study) Neurology. 2017;23:272\u201390.", "ArticleIdList": ["17679672"]}, {"Citation": "More SV, Kumar H, Kim IS, Song SY, Choi DK. Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease. Vol. 2013, Mediators of Inflammation; 2013.", "ArticleIdList": ["PMC3712244", "23935251"]}, {"Citation": "Rivera-oliver M, Manuel D, D\u00edaz-r\u00edos M. Address for correspondence\u202f: NU SC. Life Sci; 2014."}, {"Citation": "Li X, Li W, Liu G, Shen X, Tang Y. Association between cigarette smoking and Parkinson's disease: A meta-analysis. Arch Gerontol Geriatr. 2015;61(3):510\u20136.", "ArticleIdList": ["26272284"]}, {"Citation": "Avula B, Chittiboyina AG, Sagi S, Wang YH, Wang M, Khan IA. et al. Identification and quantification of vinpocetine and picamilon in dietary supplements sold in the United States. Drug Test Anal. 2016;8(3-4):334\u201343.", "ArticleIdList": ["26426301"]}, {"Citation": "Ruiz-Miyazawa KW, Zarpelon AC, Pinho-Ribeiro FA, Pav?o-De-Souza GF, Casagrande R, Verri WA. Vinpocetine reduces carrageenan-induced inflammatory hyperalgesia in mice by inhibiting oxidative stress, cytokine production and NF-?B activation in the paw and spinal cord. PLoS One; 2015. p. 10. (3)", "ArticleIdList": ["PMC4379066", "25822523"]}, {"Citation": "Wang J, Dong T, Zhang Y, Lu Z, Zhai K, Liu X. Effects of vinpocetine and ozagrel on behavioral recovery of rats after global brain ischemia. J Clin Neurosci. 2014;21(4):661\u20133.", "ArticleIdList": ["24291485"]}, {"Citation": "Hoesel B, Schmid JA. The complexity of NF-\u03baB signaling in inflammation and cancer. Mol Cancer. 2013;12(1):86.", "ArticleIdList": ["PMC3750319", "23915189"]}, {"Citation": "Liu T, Zhang L, Joo D, Sun S-C. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023.", "ArticleIdList": ["PMC5661633", "29158945"]}, {"Citation": "National Toxicology Program. Chemical Information Review Document for Vinpocetine. 2013;(42971):260."}, {"Citation": "Ratia M, Gim\u00e9nez-Llort L, Camps P, Mu\u00f1oz-Torrero D, P\u00e9rez B, Clos M V. et al. Huprine X and huperzine a improve cognition and regulate some neurochemical processes related with Alzheimer's disease in triple transgenic mice (3xTg-AD) Neurodegener Dis. 2013;11(3):129\u201340.", "ArticleIdList": ["22626981"]}, {"Citation": "Yang G, Wang Y, Tian J, Liu J-P. Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials. PLoS One [Internet] 2013;8(9):e74916.. Available from:  http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3781107&tool=pmcentrez&rendertype=abstract.", "ArticleIdList": ["PMC3781107", "24086396"]}, {"Citation": "Ma X, Gang DR. In vitro production of huperzine A, a promising drug candidate for Alzheimer's disease. Phytochemistry. 2008;69(10):2022\u20138.", "ArticleIdList": ["18538805"]}, {"Citation": "Yan R, Zhang Z, Wang Y, Yang H, Zeng Q, Zhu D. Efficient strategy for maintaining and enhancing the huperzine a production of Shiraia sp. Slf14 through inducer elicitation. J Ind Microbiol Biotechnol. 2014;41(7):1175\u20139.", "ArticleIdList": ["24865990"]}, {"Citation": "Su J, Yang M. Huperzine A production by Paecilomyces tenuis YS-13, an endophytic fungus isolated from Huperzia serrata. Nat Prod Res. 2015;29(11):1035\u201341.", "ArticleIdList": ["25427833"]}, {"Citation": "Anggono V, Tsai L, G\u00f6tz J. Glutamate Receptors in Alzheimer's Disease: Mechanisms and Therapies. Neural Plast. 2016;2016:1\u20132.", "ArticleIdList": ["PMC4884857", "27293907"]}, {"Citation": "Peters C, Sep\u00falveda FJ, Fern\u00e1ndez-P\u00e9rez EJ, Peoples RW, Aguayo LG. The Level of NMDA Receptor in the Membrane Modulates Amyloid-\u03b2 Association and Perforation. J Alzheimer's Dis. 2016;53(1):197\u2013207.", "ArticleIdList": ["27163827"]}, {"Citation": "Shao Z-Q. Comparison of the efficacy of four cholinesterase inhibitors in combination with memantine for the treatment of Alzheimer's disease. Int J Clin Exp Med. 2015;8(2):2944\u20138.", "ArticleIdList": ["PMC4402907", "25932260"]}, {"Citation": "Budni J, Bellettini-santos T, Mina F, Garcez ML. The involvement of BDNF, NGF and GDNF in aging and Alzheimer \u00e2\u20acTM s disease. 2016;6(5):331-41.", "ArticleIdList": ["PMC4567216", "26425388"]}, {"Citation": "Mao XY, Cao DF, Li X, Yin JY, Wang Z Bin, Zhang Y. et al. Huperzine a ameliorates cognitive deficits in streptozotocin-induced diabetic rats. Int J Mol Sci. 2014;15(5):7667\u201383.", "ArticleIdList": ["PMC4057698", "24857910"]}, {"Citation": "Ma T, Gong K, Yan Y, Zhang L, Tang P, Zhang X. et al. Huperzine A promotes hippocampal neurogenesis in vitro and in vivo. Brain Res. 2013;1506:35\u201343.", "ArticleIdList": ["23454433"]}, {"Citation": "Klein-Junior L, Santos Passos C, Moraes A, Wakui V, Konrath E, Nurisso A. et al. Indole Alkaloids and Semisynthetic Indole Derivatives as Multifunctional Scaffolds Aiming the Inhibition of Enzymes Related to Neurodegenerative Diseases - A Focus on Psychotria L. Genus. Curr Top Med Chem. 2014;14(8):1056\u201375.", "ArticleIdList": ["24660679"]}, {"Citation": "He D, Wu H, Wei Y, Liu W, Huang F, Shi H. et al. Effects of harmine, an acetylcholinesterase inhibitor, on spatial learning and memory of APP/PS1 transgenic mice and scopolamine-induced memory impairment mice. Eur J Pharmacol. 2015;768:96\u2013107.", "ArticleIdList": ["26526348"]}, {"Citation": "Konrath EL, Passos CDS, Klein-J\u00fanior LC, Henriques AT. Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease. J Pharm Pharmacol. 2013;65(12):1701\u201325.", "ArticleIdList": ["24236981"]}, {"Citation": "Qian W, Jin N, Shi J, Yin X, Jin X, Wang S. et al. Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) enhances tau expression. J Alzheimer's Dis. 2013;37(3):529\u201338.", "ArticleIdList": ["23948904"]}, {"Citation": "Chinwala Y, Bax L, Gallego A, Krishna K, Wright W. under the supervision of. 2016."}, {"Citation": "Vasconcelos SMM, Sales GTM, Lima N, Lobato R de FG, Mac\u00eado DS, Barbosa-Filho JM. et al. Anti-inflammatory activities of the hydroalcoholic extracts from Erythrina velutina and E. Mulungu in mice. Brazilian J Pharmacogn. 2011;21(6):1155\u20138."}, {"Citation": "de Oliveira MSG, Aquino AB, da Silva DL, Aquino PG V, Santos MS, Porf\u00edrio APR. et al. Antinociceptive and anti-infl ammatory activity of hydroalcoholic extracts and fractions from Erythrina mulungu. Brazilian J Pharmacogn. 2011;22(1):157\u201361."}]}], "History": [{"Year": "2017", "Month": "10", "Day": "9"}, {"Year": "2017", "Month": "12", "Day": "18"}, {"Year": "2018", "Month": "3", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "3", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "4", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["29559851", "PMC5859479", "10.7150/ijbs.23247", "ijbsv14p0341"]}}]}